Anti-Saccharomyces cerevisiae Antibodies Are Associated With the Development of Postoperative Fistulas Following Ileal Pouch-Anal Anastomosis

Journal of Gastrointestinal Surgery

Volumn 10, Issue 7, 2006, Pages 1060-1064

  Dendrinos, Kleanthis G ^a   Becker, James M ^a   Stucchi, Arthur F ^a   Saubermann, Lawrence J ^a   LaMorte, Wayne ^a   Farraye, Francis A ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

ASCA; fistulas; ileal pouch anal anastomosis; pANCA

Indexed keywords

BIOLOGICAL MARKER; FUNGUS ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANAL CANAL; ANASTOMOSIS; ARTICLE; BLOOD; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; ILEITIS; ILEUM; IMMUNOLOGY; INTESTINE FISTULA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANAL CANAL; ANASTOMOSIS, SURGICAL; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; ILEUM; INTESTINAL FISTULA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROCTOCOLECTOMY, RESTORATIVE; RETROSPECTIVE STUDIES; SACCHAROMYCES CEREVISIAE;

EID: 33745857632     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2006.02.004     Document Type: Article

References (24)

1. Joossens S., Reinisch W., Vermeire S., et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 122 (2002) 1242-1247
2. Bayless T.M., and Hanauer S.B. Advanced Therapy of IBD (2001), BC Dekker, London
3. Odze R.D. Pathology of indeterminate colitis. J Clin Gastroenterol 38 5 Suppl (2004) S36-S40
4. Becker J.M., and Stucchi A.F. Proctocolectomy with ileoanal anastomosis. J Gastrointest Surg 8 (2004) 376-386
5. Peyregne V., Francois Y., Gilly F.N., et al. Outcome of ileal pouch after secondary diagnosis of Crohn's disease. Int J Colorectal Dis 15 (2000) 49-53
6. Lepisto A., Luukkonen P., and Jarvinen H.J. Cumulative failure rate of ileal pouch-anal anastomosis and quality of life after failure. Dis Colon Rectum 45 (2002) 1289-1294
7. Alexander F., Sarigol S., DiFiore J., et al. Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg 38 (2003) 78-82
8. Fazio V.W., Tekkis P.P., Remzi F., et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg Ann Surg 238 (2003) 605-614
9. Dubinsky M.C., Ofman J.J., Urman M., et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 96 (2001) 758-765
10. Nakamura R.M., Matsutani M., and Barry M. Advances in clinical laboratory test for inflammatory bowel disease. Clin Chim Acta 335 (2003) 9-20
11. Halme L., Turunen U., Helio T., et al. Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 37 (2002) 692-698
12. Lecis P., Germana B., Papa N., et al. pANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease. Recent Prog Med 93 (2002) 308-313
13. Bartunkova J., Kolarova I., Sediva A., et al. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Clin Immunol 102 (2002) 162-168
14. Glas J., Torok H.P., Vilsmaier F., et al. Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value. Digestion 66 (2002) 173-177
15. Oshitani N., Hato F., Suzuki K., et al. Cross reactivity of yeast antigens in human colon and peripheral leukocytes. J Pathol 199 (2003) 361-367
16. Fleshner P.R., Vasiliauskas E.A., Kam L.Y., et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 49 (2001) 671-677
17. Sandborn W.J., Landers C.J., Tremaine W.J., et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 90 (1995) 740-747
18. Kaditis A.G., Perrault J., Sandborn W.J., et al. Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis. J Pediatr Gastroenterol Nutr 26 (1998) 386-392
19. Aisenberg J., Legnani P.E., Nilubol N., et al. Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 99 (2004) 432-441
20. Saxon A., Shanahan F., Landers C., et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86 (1990) 202-210
21. Vidrich A., Lee J., James E., et al. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J Clin Immunol 15 (1995) 293-299
22. Smith B.R., Arnott I.D., Drummond H.E., et al. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease. Inflamm Bowel Dis 10 (2004) 521-528
23. Walker L.J., Aldhous M.C., Drummond H.E., et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol 135 (2004) 490-496
24. Forcione D.G., Rosen M.J., Kisiel J.B., et al. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 53 (2004) 1117-1122